Advertisement NMT Medical names new interim president and CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

NMT Medical names new interim president and CEO

NMT Medical, a medical technology company, has appointed NMT board member Frank Martin as its new interim president and CEO.

Until a permanent successor is appointed, Mr Martin will assume the responsibilities formerly held by John Ahern. Mr Ahern has announced his retirement and has also resigned from his position as a director of the company. NMT’s board has begun the search for a permanent CEO and has retained an executive recruiting firm.

NMT Medical has also announced that Richard Davis, the company’s current executive vice president and CFO, was promoted to the newly created position of COO. Mr Davis will retain the CFO role.

James Mahoney, Jr, chairman of the board at NMT, said: “Frank Martin is the ideal candidate to assume the interim CEO role Martin is the ideal candidate to assume the interim CEO role. Frank has a wealth of experience in sales, marketing and fundraising for medical device companies that are essential to the future success of NMT. We are delighted that he has accepted this position.”